ATE398460T1 - Vorbeuge- und/oder heilmittel für das multiple organversagen - Google Patents

Vorbeuge- und/oder heilmittel für das multiple organversagen

Info

Publication number: ATE398460T1
Authority: AT; Austria
Prior art keywords: multiple organ; failure; organ failure; preventing; agent
Prior art date: 1997-03-11

Application number

AT98907158T

Other languages

English (en)

Inventor

Hirohiko Arisawa

Hiroaki Masunaga

Hiromi Ogawa

Kanji Higashio

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-11

Filing date

1998-03-11

Publication date

2008-07-15

1998-03-11 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2008-07-15 Application granted granted Critical

2008-07-15 Publication of ATE398460T1 publication Critical patent/ATE398460T1/de

Links

208000034486 Multi-organ failure Diseases 0.000 title abstract 3
208000010718 Multiple Organ Failure Diseases 0.000 title abstract 3
208000029744 multiple organ dysfunction syndrome Diseases 0.000 title abstract 3
230000003449 preventive effect Effects 0.000 title 1
208000030507 AIDS Diseases 0.000 abstract 2
102000003745 Hepatocyte Growth Factor Human genes 0.000 abstract 2
108090000100 Hepatocyte Growth Factor Proteins 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
206010006895 Cachexia Diseases 0.000 abstract 1
206010009192 Circulatory collapse Diseases 0.000 abstract 1
208000035473 Communicable disease Diseases 0.000 abstract 1
208000012671 Gastrointestinal haemorrhages Diseases 0.000 abstract 1
208000032456 Hemorrhagic Shock Diseases 0.000 abstract 1
206010033645 Pancreatitis Diseases 0.000 abstract 1
206010033647 Pancreatitis acute Diseases 0.000 abstract 1
108010094028 Prothrombin Proteins 0.000 abstract 1
206010049771 Shock haemorrhagic Diseases 0.000 abstract 1
201000003229 acute pancreatitis Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 1
231100000433 cytotoxic Toxicity 0.000 abstract 1
230000001472 cytotoxic effect Effects 0.000 abstract 1
230000006866 deterioration Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
208000009190 disseminated intravascular coagulation Diseases 0.000 abstract 1
201000011200 hepatorenal syndrome Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
230000000302 ischemic effect Effects 0.000 abstract 1
230000002503 metabolic effect Effects 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
230000005855 radiation Effects 0.000 abstract 1
206010040560 shock Diseases 0.000 abstract 1
230000009885 systemic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Jib Cranes (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

AT98907158T 1997-03-11 1998-03-11 Vorbeuge- und/oder heilmittel für das multiple organversagen ATE398460T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP7437297		1997-03-11
JP15764597A JP4006058B2 (ja)	1997-03-11	1997-05-30	多臓器不全予防及び／又は治療剤

Publications (1)

Publication Number	Publication Date
ATE398460T1 true ATE398460T1 (de)	2008-07-15

Family

ID=26415513

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98907158T ATE398460T1 (de)	1997-03-11	1998-03-11	Vorbeuge- und/oder heilmittel für das multiple organversagen

Country Status (9)

Country	Link
US (2)	US20010051146A1 (de)
EP (1)	EP0914829B1 (de)
JP (1)	JP4006058B2 (de)
AT (1)	ATE398460T1 (de)
AU (1)	AU725441B2 (de)
CA (1)	CA2252711A1 (de)
DE (1)	DE69839621D1 (de)
ES (1)	ES2308802T3 (de)
WO (1)	WO1998040096A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4006058B2 (ja)	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
ES2274567T3 (es)	1997-03-14	2007-05-16	Daiichi Pharmaceutical Co., Ltd.	Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JPH1129493A (ja) *	1997-07-14	1999-02-02	Snow Brand Milk Prod Co Ltd	放射線障害予防及び／又は治療剤
CA2410918A1 (en) *	2000-06-02	2002-11-29	Hiroshi Okamoto	Agents for proliferating pancreatic beta-cells of the islets of langerhans, agents for suppressing apoptosis of said cells, and screening of candidate compounds for these agents
GB0110430D0 (en) *	2001-04-27	2001-06-20	Medical Res Council	Protein variants and uses thereof
WO2003037365A1 (en) *	2001-11-01	2003-05-08	The Johns Hopkins University	Methods and compositions for treating vascular leak using hepatocyte growth factor

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3904753A (en)	1970-02-20	1975-09-09	Research Corp	Clinically active bovine growth hormone fraction
US4076701A (en)	1975-07-29	1978-02-28	Immunology Research Foundation, Inc.	Tumor complement fraction recovery method and product
US4490549A (en)	1977-04-19	1984-12-25	The Upjohn Company	Enlarged-hetero-ring prostacyclin analogs
US4481137A (en)	1982-02-26	1984-11-06	Mochida Pharmaceutical Co., Ltd.	Glycoproteins and processes for their production
JPS60112718A (ja)	1983-11-21	1985-06-19	Kyorin Pharmaceut Co Ltd	抗腫瘍作用を示す蛋白性物質及びその製造方法
US4650674A (en)	1984-07-05	1987-03-17	Genentech, Inc.	Synergistic cytotoxic composition
ATE41159T1 (de)	1985-08-29	1989-03-15	Berol Kemi Ab	Traeger mit einer immobilisierten biologischaktiven substanz, verfahren zur herstellung und seine verwendung.
US4870163A (en)	1985-08-29	1989-09-26	New York Blood Center, Inc.	Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
US4822605A (en)	1986-02-18	1989-04-18	Exovir, Inc.	Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
KR890009412A (ko)	1987-12-22	1989-08-01	마쓰시따 렌조오	종양 세포 억제 인자
JPH0296598A (ja)	1988-10-03	1990-04-09	Sapporo Breweries Ltd	リンフォカイン活性化キラー細胞誘導抑制因子ｌａｋｓｆ，その製造法およびそれを有効成分とする免疫抑制剤
NZ232813A (en)	1989-03-10	1992-08-26	Snow Brand Milk Products Co Ltd	Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5035887A (en)	1989-09-07	1991-07-30	Institute Of Moelcular Biology, Inc.	Wound healing composition of IL-1 and PDGF or IGF-1
US5362716A (en)	1989-12-27	1994-11-08	The United States Of America As Represented By The Department Of Health And Human Services	Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
US5648273A (en)	1989-12-27	1997-07-15	The United States Of America, As Represented By The Department Of Health And Human Services	Hepatic growth factor receptor is the MET proto-oncogene
JP2784455B2 (ja)	1990-05-09	1998-08-06	敏一中村	肝硬変治療剤
DE69133492T2 (de)	1990-06-11	2006-08-10	Nakamura, Toshikazu	Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
JP2750372B2 (ja) *	1990-06-19	1998-05-13	敏一中村	賢疾患治療剤
ATE178354T1 (de)	1990-07-13	1999-04-15	Snow Brand Milk Products Co Ltd	Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
US5821223A (en)	1990-09-14	1998-10-13	The United States Of America As Represented By The Department Of Health And Human Services	Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
IL100899A (en)	1991-02-08	1997-06-10	Sankyo Co	Beta-amino-alpha- hydroxycarboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
JPH0597A (ja)	1991-06-21	1993-01-08	Snow Brand Milk Prod Co Ltd	新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
JP3394982B2 (ja)	1991-11-07	2003-04-07	敏一中村	ガン療法用副作用防止剤
WO1993013066A1 (en)	1991-12-20	1993-07-08	Syntex (U.S.A.) Inc.	Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors
JP3123617B2 (ja)	1992-03-04	2001-01-15	雪印乳業株式会社	シアル酸結合を有する化合物の製造法
JPH0625273A (ja) *	1992-03-31	1994-02-01	Dai Ichi Seiyaku Co Ltd	アミノ糖誘導体
NO178729C (no)	1992-03-31	1996-05-22	Daiichi Seiyaku Co	Terapeutisk aktive sukkerderivater
US5315000A (en)	1992-05-14	1994-05-24	Children's Hospital Medical Center	Gene encoding for a L5/3 growth factor and its CDNA
WO1993023541A1 (en)	1992-05-18	1993-11-25	Genentech, Inc.	Hepatocyte growth factor variants
AU674871B2 (en)	1992-07-16	1997-01-16	Atlas Pharmaceuticals Inc.	Blood coagulation normalizer containing TCF-II as active ingredient
JPH0656692A (ja) *	1992-08-10	1994-03-01	Snow Brand Milk Prod Co Ltd	Ｔｃｆ−ｉｉを有効成分とする創傷治療剤
JP3380573B2 (ja) *	1992-07-16	2003-02-24	第一製薬株式会社	Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
JP3619526B2 (ja)	1992-07-16	2005-02-09	第一製薬株式会社	Ｔｃｆ−ｉｉを有効成分とする肝臓疾患治療剤
DK0588477T3 (da) *	1992-07-16	1998-03-30	Snow Brand Milk Products Co Ltd	Medicinsk præparat omfatende TCF-11
JP3697460B2 (ja) *	1992-07-17	2005-09-21	敏一中村	Ｈｇｆ含有製剤
AU662434B2 (en)	1992-08-07	1995-08-31	Sankyo Company Limited	Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
JP3402476B2 (ja)	1992-08-24	2003-05-06	生化学工業株式会社	リポ多糖結合性タンパク質及びその製造法
DE69310525T2 (de)	1992-09-16	1997-10-02	Genentech Inc	Schutz gegen leberschäden mit hgf
US5703047A (en)	1992-09-21	1997-12-30	Board Of Regents, The University Of Texas System	Methods and treatments for corneal healing with growth factors
US5589451A (en)	1992-09-21	1996-12-31	Board Of Regents, The University Of Texas System	Methods and treaments for corneal healing with hepatocyte and keratinocyte growth factors
JPH06116299A (ja)	1992-10-02	1994-04-26	Snow Brand Milk Prod Co Ltd	特定の糖鎖構造により高い生物活性を有する遺伝子組換え型ｔｃｆ
US5554653A (en)	1992-12-22	1996-09-10	Eli Lilly And Company	Inhibitors of HIV protease useful for the treatment of AIDS
MX9308016A (es)	1992-12-22	1994-08-31	Lilly Co Eli	Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
WO1994014845A1 (en)	1992-12-28	1994-07-07	Snow Brand Milk Products Co., Ltd.	Modified tcf
JP3552240B2 (ja)	1993-02-23	2004-08-11	第一製薬株式会社	高濃度ｔｃｆ製剤
JPH07258298A (ja)	1994-03-18	1995-10-09	Snow Brand Milk Prod Co Ltd	モノクローナル抗体
JP3962097B2 (ja)	1994-03-18	2007-08-22	敏一中村	免疫抑制剤による副作用の軽減剤
US5707624A (en)	1994-06-03	1998-01-13	The Regents Of The University Of Michigan	Treatment of Kaposi's sarcoma by inhibition of scatter factor
DE69531673T2 (de)	1994-12-27	2004-07-08	Daiichi Pharmaceutical Co., Ltd.	Tcf mutante
NZ298141A (en) *	1994-12-27	2000-12-22	Snow Brand Milk Products Co Ltd	Treating lipid metabolism disorder using TCF-II
JPH08231418A (ja)	1995-02-24	1996-09-10	Mitsubishi Chem Corp	腸疾患治療剤
AU4953796A (en)	1995-03-15	1996-10-02	Sanyko Company, Limited	Dipeptide compounds having ahpba structure
JP3859710B2 (ja)	1995-04-21	2006-12-20	三菱化学株式会社	虚血性疾患の予防及び／又は治療剤
JPH10194986A (ja)	1996-06-10	1998-07-28	Snow Brand Milk Prod Co Ltd	移植肝機能改善・再生促進剤
JP3887435B2 (ja)	1996-07-12	2007-02-28	第一製薬株式会社	スフェロイド形成促進剤
JPH1068400A (ja)	1996-08-28	1998-03-10	Tetsuo Taira	液体を押し出すボトルポンプ及びその方法と製造方法
JP4006058B2 (ja)	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
ES2274567T3 (es)	1997-03-14	2007-05-16	Daiichi Pharmaceutical Co., Ltd.	Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JP3961064B2 (ja)	1997-03-28	2007-08-15	第一製薬株式会社	腎疾患予防及び／又は治療剤
JPH1129493A (ja)	1997-07-14	1999-02-02	Snow Brand Milk Prod Co Ltd	放射線障害予防及び／又は治療剤
JPH11269091A (ja)	1998-03-19	1999-10-05	Snow Brand Milk Prod Co Ltd	敗血症予防及び／又は治療剤

1997
- 1997-05-30 JP JP15764597A patent/JP4006058B2/ja not_active Expired - Fee Related
1998
- 1998-03-11 DE DE69839621T patent/DE69839621D1/de not_active Expired - Fee Related
- 1998-03-11 EP EP98907158A patent/EP0914829B1/de not_active Expired - Lifetime
- 1998-03-11 WO PCT/JP1998/000998 patent/WO1998040096A1/ja not_active Ceased
- 1998-03-11 AT AT98907158T patent/ATE398460T1/de not_active IP Right Cessation
- 1998-03-11 AU AU63092/98A patent/AU725441B2/en not_active Ceased
- 1998-03-11 CA CA002252711A patent/CA2252711A1/en not_active Abandoned
- 1998-03-11 US US09/180,599 patent/US20010051146A1/en not_active Abandoned
- 1998-03-11 ES ES98907158T patent/ES2308802T3/es not_active Expired - Lifetime
2002
- 2002-12-11 US US10/317,011 patent/US7306791B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0914829A1 (de)	1999-05-12
EP0914829A4 (de)	2004-06-16
EP0914829B1 (de)	2008-06-18
US20030153489A1 (en)	2003-08-14
WO1998040096A1 (en)	1998-09-17
DE69839621D1 (de)	2008-07-31
ES2308802T3 (es)	2008-12-01
JPH10310535A (ja)	1998-11-24
AU725441B2 (en)	2000-10-12
CA2252711A1 (en)	1998-09-17
US7306791B2 (en)	2007-12-11
AU6309298A (en)	1998-09-29
JP4006058B2 (ja)	2007-11-14
US20010051146A1 (en)	2001-12-13

Legal Events

Date	Code	Title	Description
2008-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ES2167377T3 (es)	2002-05-16	Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
TR200100805T2 (tr)	2001-08-21	Tetrahidropiridoeterler
NO20014662D0 (no)	2001-09-25	Fremgangsmåter og preparater for behandling av faste tumorer
ATE175671T1 (de)	1999-01-15	Heterocyclylcarbonylsubstituierte benzofuranyl- und -thiophenylalkancarbonsäurederivate
TR200102612T2 (tr)	2002-06-21	Mide asidi salgılanmasını önleyen imidazo piridin türevleri.
DE60040012D1 (de)	2008-10-02	Rekombinantes gelatin in impstoffen
SE7611379L (sv)	1977-04-15	Antihypertensiva medel
PL375560A1 (pl)	2005-11-28	Kompozycja farmaceutyczna
JP2002532112A5 (de)	2005-06-02
DE69922885D1 (de)	2005-02-03	Endoluminal einführbare stents und ihre herstellung
DE69817802D1 (de)	2003-10-09	Substituierte phenylderivate, ihre herstellung und verwendung
ES2192839T3 (es)	2003-10-16	Timosina beta 4 oxidada.
DZ3196A1 (fr)	2001-04-05	Dérivés d'acide indolyl-3-glyoxyle à bonnes proprietes thérapeutiques.
ATE35416T1 (de)	1988-07-15	Derivate des glycerophosphocholins und glycerophosphoethanolamins, ihre herstellung und verwendung.
TR199802554T2 (xx)	1999-03-22	Yeni bile�ikler
DE60115466D1 (de)	2006-01-05	Wirkstoffvorläufer von imidazopyridin-derivaten
DE69839621D1 (de)	2008-07-31	Anversagen
NO20011281L (no)	2001-05-14	Insekticid preparat
DE69831559T2 (de)	2006-06-14	Substituierte (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8yl)phenyl derivate, deren herstellung und deren verwendung in der behandlung von entzündungen und immunkrankheiten
ES2154311T3 (es)	2001-04-01	Quinoxalinas, procedimiento para su preparacion y su utilizacion.
ES2174396T3 (es)	2002-11-01	Vela odorifera y su procedimiento de fabricacion.
ES2164765T3 (es)	2002-03-01	Heterociclilbenzonitrilos.
DE69524388D1 (de)	2002-01-17	4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
JPH10310535A5 (de)	2005-03-03
ZA982068B (en)	1998-09-16	Agent for preventing and/or treating cachexia